We are currently offering only the Pfizer–BioNTech and Moderna COVID-19 vaccines to our eligible patients. We are notifying patients individually when they can schedule a vaccination appointment. so we can notify you. Learn more about the .
Though schizophrenia is a chronic, or long-term, condition, it is highly treatable with medication and other therapies. NYU Langone experts provide support services to people with schizophrenia and their families.
NYU Langone specialists educate people with schizophrenia about the condition and encourage them to take an active role in their treatment. This might involve working with a doctor to determine the best medication or psychosocial therapy goal. After people learn about the condition, they can make an informed decision about their care.
In addition, knowing the early warning signs of a psychotic episode or relapse can help a person respond to it—and even prevent it.
People with schizophrenia may be hospitalized at times, and symptoms can make it difficult to stay in school or keep a job. Experts at NYU Langone work with community agencies to help people return to work or school. Our specialists can connect people who have schizophrenia and their families to appropriate services, such as social workers, educational programs, and community support groups.
People who have schizophrenia may benefit from participating in clinical trials. During a clinical trial, new medications, medical devices, or other treatments are evaluated. These studies are required for regulatory approval of new therapies.
NYU Langone doctors maintain an active research program dedicated to investigating new diagnostic methods and medications that could help to treat schizophrenia. People with this condition should talk to their doctors about whether a clinical trial is right for them.
Learn more about our research and professional education opportunities.